Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000700124 | SCV000828866 | pathogenic | Qualitative or quantitative defects of dysferlin | 2023-09-04 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 6666). This premature translational stop signal has been observed in individuals with myopathy (PMID: 9731526, 11198284, 17698709, 18853459, 22194990). This variant is present in population databases (rs766993624, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Gly1865Alafs*101) in the DYSF gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DYSF are known to be pathogenic (PMID: 17698709, 20301480). |
Revvity Omics, |
RCV001781197 | SCV002021857 | pathogenic | not provided | 2019-05-13 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003466822 | SCV004194185 | pathogenic | Miyoshi muscular dystrophy 1 | 2023-12-16 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000007048 | SCV000027244 | pathogenic | Distal myopathy with anterior tibial onset | 2001-01-01 | no assertion criteria provided | literature only |